-
MendaCel is a proprietary wound care device
-
MendaCel combines proven treatment modalities into a dynamic delivery system for at-home wound care
-
Patent-pending, working prototypes, FDA 510(k) exempt.
-
Verified for manufacturability and regulatory exemption by Life Science company Boulder IQ
-
NIH Phase 1 SBIR/STTR Application successfully submitted
-
US Army MRDC BAA pre-application pending
-
Currently raising Seed Funding. Represented by Wilson Sonsini
MedTech World Article: MendaCel Inc Introduce Cutting-Edge Wound Care Device
